MDLZ vs PTHS · P/E 30, rev $38.54B vs rev $16.8M
Mondelez International Inc (MDLZ) versus Pelthos Therapeutics Inc. (PTHS) — a side-by-side from cached financials, not a winner call.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.
MDLZ currently screens at market cap $78.12B and trailing P/E 30.1. PTHS currently screens at market cap $94.7M.
Not investment advice. Open the MDLZ and PTHS stock pages for the full models.
Not investment advice.